Effect of TSLC1 gene on proliferation, invasion and apoptosis of human hepatocellular carcinoma cell line HepG2

Abstract

The recombinant plasmid pCI-TSLC1 carrying TSLC1 gene was stably transfected into human hepatocellular carcinoma cell line HepG2. Cell proliferation was analyzed by MTT assay. The ability of migration was determined by transwell and FACSort flow cytometry was used to detect the cell cycle distribution and apoptosis. Western blotting revealed that H4 expressed higher amounts of TSLC1 protein than H15 and H0 did. The growth of TSLC1-transfected cells was significantly suppressed in vitro, and the ability of migration was reduced as well. The re-expression of TSLC1 could induce cell apoptosis. It was concluded that TSLC1 strongly inhibited the growth and ability of migration of HepG2 cell line in vitro and also induced apoptosis, suggesting that TSLC1 could reduce the tumorigenicity of human hepatocellular carcinoma cell line HepG2 in vitro, which provided a basis for further exploring the roles of TSLC1 in hepatocellular cellular carcinoma.

Keywords

carcinoma / hepatocellular / TSLC1 gene / proliferation / invasion / apoptosis

References

[1] KuramochiM., FukuharaH., NobukuniT., et al.. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet, 2001, 27: 427-430

[2] HondaT., TamuraG., WakiT., et al.. Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines. Jpn J Cancer Res, 2002, 93: 857-860

[3] UchinoK., ItoA., WakayamaT., et al.. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung. Cancer, 2003, 98: 1002-1007

[4] FukuharaH., KuramochiM., FukamiT., et al.. Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer. Jpn J Cancer Res, 2002, 93: 605-609

[5] JansenM., FukushimaN., RostyC., et al.. Aberrant methylation of the 5′ CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade Pan1Ns. Cancer Biol Ther, 2002, 1: 293-296

[6] TamuraG.. Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia. Histol Histopathol, 2004, 19: 221-228

[7] AllinenM., PeriL., KujalaS., et al.. Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation. Genes Chromosomes Cancer, 2002, 34: 384-389

[8] YagetaM., KuramochiM., MasudaM., et al.. Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer. Cancer Res, 2002, 62: 5129-5133

[9] FukuharaH., MasudaM., YagetaM., et al.. Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of drosophila tumor suppressor Dlg. Oncogene, 2003, 22: 6160-6165

[10] BolesK. S., BarchetW., DiacovoT., et al.. The tumor suppressor TSLC1/NECL-2 triggers NK cell and CD8+ T cell responses through the cell surface receptor CRTAM. Blood, 2005, 106: 779-786

[11] SasakiH., NishikataI., ShiragaT., et al.. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute type of adult T-cell leukemia. Blood, 2005, 105: 1204-1213